Change for childhood cancer starts here.

$16,082 raised$15,000 goal
Support our life saving research

Donate before 31 December 2024!

Children diagnosed with a blood cancer undergo an intensive and highly toxic treatment regimen that can last up to 9 months, with the majority of that time spent in hospital. Diagnoses and treatments are stuck in the past.

Severe immune suppression resulting from the blood cancer and the high dose chemotherapy means already very sick children face a significant risk of dying from infection during their treatment.

While high intensity chemotherapy and/or bone marrow transplant can cure cancer in many children, a significant number of children who survive will endure life-long and life-altering side effects. These include cardiac toxicities, cognitive issues or diagnosis of a secondary cancer later in life and infertility.

There is a critical need to better understand how blood cancer develops and to identify ways in which cancer cells learn to evade and resist therapy. This enhanced understanding will pave the way for development of new and improved ways to treat children in better ways with increased efficacy and reduced toxicity.

Better, safer cancer treatments for children. Support our life saving research now.

Leukaemia accounts for approximately 30% of all chi;dhood cancers and 20% of childhood cancer deaths.

Support life saving medical research.

Our Hudson Institute researchers are working on new and improved ways to treat children with cancer to lift survival rates and achieve better outcomes for children.
Our Hudson Institute researchers are working on new and improved ways to treat children with cancer to lift survival rates and achieve better outcomes for children.

Cancer can affect anyone at any time. Every day at Hudson, researchers are working to help find cures and treatments that could one day help your family, or someone close to you.

They are working to understand how blood cancer develops in children, and to identify ways in which cancer cells learn to evade and resist therapy. This is critical to finding better ways to treat children with cancer. We are working to ensure better efficacy and to reduce toxicity from cancer treatments for children.

Our teams are leaders in children’s cancer research. This work is critical. It could help someone you love. And we need the support of generous donors to power this work.

Dr Catherine Carmichael and her team of researchers Ms Jin Luo, Thao Nguyen, Steve Lin and Lynda Truong in their lab at Hudson Institute.

Dr Catherine Carmichael and her team of researchers Ms Jin Luo, Thao Nguyen, Steve Lin and Lynda Truong in their lab at Hudson Institute.

Leukaemia is the most common cancer type and second leading cause of cancer related death in children.
Survival rates for Acute Lymphoblastic Leukaemia (ALL) is about 90% now woth improved therapies, while survival rates for Acute Myeloid Leukaemia (AML) are around 65%.

100% of your donation goes to childhood cancer research.

Cancer can affect anyone at any time. Every day at Hudson, researchers are working to help find cures and treatments that could one day help a child in your family, or someone close to you.

100% of your donation goes to childhood cancer research.

Cancer can affect anyone at any time. Every day at Hudson, researchers are working to help find cures and treatments that could one day help a child in your family, or someone close to you.

Our generous supporters

Loading interface...
Loading interface...
Loading interface...
Loading interface...
Loading interface...

You are currently on page NaN of 2

Donate today

Support our life saving research.

Donate before 31 December 2024!

$16,082 raised$15,000 goal
$16,082 raised$15,000 goal

Hudson Institute is a global leader in medical research. We make break-through discoveries that change lives.

Hudson Institute is a global leader in medical research. We make break-through discoveries that change lives.